首页 > 市场调查报告书 > 医疗设备

眼科设备手术用器具

市场调查报告书

商品编码

1569464

青光眼手术设备市场规模、份额和成长分析：按产品、手术方法、最终用途、地区 - 产业预测，2024-2031 年

Glaucoma Surgery Devices Market Size, Share, Growth Analysis, By Product, By Surgery Method, By End-use, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年青光眼手术设备的全球市场规模为14亿美元，从2023年的14.7亿美元增长到2031年的21.2亿美元，并且预计在预测期内（2024-2031年）将会增长。为4.70%。

青光眼手术器械市场有望显着成长，这主要是由于全球青光眼盛行率不断上升，特别是在人口老化中。随着这种眼科疾病率的增加，对有效手术介入措施的需求也在增加，手术技术的进步显着提高了成功率和安全性。人们观察到微创青光眼手术 (MIGS) 发生了重大转变，青光眼引流系统和雷射设备等设备由于併发症发生率较低和患者治疗效果改善而越来越受欢迎。微创手术的趋势以小梁微旁路支架和脉络膜上分流术等技术为特色，透过促进与白内障手术的联合干预，同时缩短恢復时间，正在彻底改变市场。患者和医疗保健提供者对青光眼早期检测和早期疗育重要性的认识不断提高，进一步推动了市场的采用。此外，有利的报销制度正在支持市场扩张，特别是在北美和欧洲等新兴市场。随着强调以患者为中心的护理以促进更好的手术结果，MIGS 的采用不断增加，并成为成长的关键驱动力。根据预测，美国青光眼手术器械市场预计在接下来的预测期内将保持健康的复合年增长率，凸显了该行业的未来性。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Alcon, Inc.（Switzerland）
Glaukos Corporation（US）
Johnson & Johnson Vision（US）
ASICO, LLC（US）
Carl Zeiss Meditec AG（Germany）
Ziemer Ophthalmic Systems AG（Switzerland）
Iridex Corporation（US）
Altomed（UK）
New World Medical, Inc.（US）
Ellex Medical Lasers Ltd.（Australia）
Topcon Corporation（Japan）
BVI Medical, Inc.（US）
MicroSurgical Technology（MST）（US）
Molteno Ophthalmic Ltd.（New Zealand）
OptoMedica Corporation（US）
iStar Medical SA（Belgium）
NeoMedix Corporation（US）
Sight Sciences, Inc.（US）
Aquesys, Inc.（US）
IOP Ophthalmics（US）
Katena Products, Inc.（US）

简介目录

Product Code: SQMIG35A2402

Global Glaucoma Surgery Devices Market size was valued at USD 1.40 billion in 2022 and is poised to grow from USD 1.47 billion in 2023 to USD 2.12 billion by 2031, growing at a CAGR of 4.70% during the forecast period (2024-2031).

The glaucoma surgery devices market is on the brink of significant growth, primarily fueled by the escalating global incidence of glaucoma, particularly among the aging population. As the prevalence of this eye condition rises, the demand for effective surgical interventions is also increasing, supported by advancements in surgical techniques that have markedly improved success rates and safety profiles. A notable shift toward minimally invasive glaucoma surgery (MIGS) has been observed, with devices like glaucoma drainage systems and laser equipment gaining popularity for their reduced complication rates and enhanced patient outcomes. The trend toward less invasive procedures, characterized by techniques such as trabecular micro-bypass stents and suprachoroidal shunts, is revolutionizing the market, allowing for shorter recovery periods while facilitating combined interventions with cataract surgeries. Increased awareness among patients and healthcare providers about the critical importance of early glaucoma detection and intervention further drives market adoption. Additionally, favorable reimbursement frameworks, especially in developed regions like North America and Europe, bolster market expansion. With a heightened emphasis on patient-centered care that promotes better surgical outcomes, the adoption of MIGS is set to continue its upward trajectory, making it a pivotal driver of growth. According to projections, the US glaucoma surgery devices market is anticipated to sustain a healthy compound annual growth rate (CAGR) in the upcoming forecast period, underscoring the promising future of this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the global glaucoma surgery devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global glaucoma surgery devices Market Segmental Analysis

Global Glaucoma Surgery Devices Market is segmented by Product, Surgery Method, End-use, and region. Based on Product, the market is segmented into Glaucoma Drainage Device, Traditional Surgery Devices, Diamond Knives, Laser Systems, and Others. Based on Surgery Method, the market is segmented into Traditional Glaucoma Surgery, Minimal Invasive Glaucoma Surgery, and Laser Surgery. Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global glaucoma surgery devices Market

The global glaucoma surgery devices market is significantly driven by the aging population and a rise in lifestyle-related factors, including prolonged screen time and an increase in diabetes prevalence, which contribute to a higher incidence of glaucoma. This escalating prevalence necessitates effective surgical interventions, thus intensifying the demand for advanced glaucoma surgery devices. Additionally, heightened awareness among healthcare providers and patients regarding the critical importance of early detection and timely treatment of glaucoma amplifies this market growth. As the healthcare landscape continues to evolve, the pressing need for innovative surgical solutions to combat glaucoma will further bolster the market's expansion.

Restraints in the global glaucoma surgery devices Market

The global glaucoma surgery devices market faces a significant restraint due to the high cost associated with surgical procedures. Factors including the necessity for advanced, specialized equipment, the requirement for highly skilled healthcare providers, and comprehensive post-operative care contribute to increased expenses. Additionally, the cost of the devices themselves adds to the financial burden, making glaucoma surgeries unaffordable for many patients, particularly in developing regions or among those lacking sufficient insurance coverage. This economic barrier not only restricts patient access to essential surgical interventions but also hampers the overall growth potential of the glaucoma surgery devices market.

Market Trends of the global glaucoma surgery devices Market

The global glaucoma surgery devices market is witnessing a significant trend towards combination therapies, which integrate various treatment modalities to optimize intraocular pressure (IOP) management. This approach enhances therapeutic outcomes by leveraging the synergistic effects of medications, laser treatments, and surgical techniques. The emergence of advanced glaucoma devices that incorporate drug-delivery systems, such as sustained-release implants, exemplifies this trend, allowing for targeted and controlled drug administration alongside surgical interventions. As healthcare providers increasingly adopt these innovative solutions, the market is positioned for robust growth, driven by the demand for more effective and personalized glaucoma treatment options.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Glaucoma Surgery Devices Market by Product

Market Overview
Glaucoma Drainage Device
- Valves
- Glaucoma Drainage Implant
- Glaucoma Tube Shunts
- Stents
Traditional Surgery Devices
- Scalpel
- Forceps
- Ophthalmic Scissors
- Punch
- Sutures
- Surgical Drapes
- Microcatheter
- Others
Diamond Knives
Laser Systems
Others

Glaucoma Surgery Devices Market by Surgery Method

Market Overview
Traditional Glaucoma Surgery
- Trabeculectomy
- Tube Shunt Surgery
Minimal Invasive Glaucoma Surgery
- Trabecular Meshwork Bypass
- Suprachoroidal Space Implants
- Subconjunctival Space Implants
- Schlemm's Canal Implants
- Gonioscopy-assisted Transluminal Trabeculectomy
- Endocyclophotocoagulation
Laser Surgery
- Trabeculoplasty
- Iridotomy
- Cyclophotocoagulation

Glaucoma Surgery Devices Market by End-use

Market Overview
Hospitals
Ophthalmic Clinics
Others

Glaucoma Surgery Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Alcon, Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glaukos Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Vision (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ASICO, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss Meditec AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ziemer Ophthalmic Systems AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Iridex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altomed (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New World Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ellex Medical Lasers Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Topcon Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BVI Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroSurgical Technology (MST) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molteno Ophthalmic Ltd. (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OptoMedica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
iStar Medical SA (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoMedix Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sight Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aquesys, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IOP Ophthalmics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Katena Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments